CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase 1 Study to Evaluate [18F]ACI-15916 as a Potential PET Radioligand for Imaging α-synuclein Deposits in the Brain of Patients With Suspected α-synuclein Pathology Compared With Healthy Volunteers
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06891703
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:58.224367+00:00
- Published At
- 2025-11-19T00:00:00+00:00
- Record Updated At
- 2025-11-19
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Parkinson\u0027s Disease (PD)", "Multiple System Atrophy (MSA)", "Dementia With Lewy Bodies (DLB)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-19"- protocolSection.identificationModule.nctId
"NCT06891703"- protocolSection.identificationModule.officialTitle
"Phase 1 Study to Evaluate [18F]ACI-15916 as a Potential PET Radioligand for Imaging \u03b1-synuclein Deposits in the Brain of Patients With Suspected \u03b1-synuclein Pathology Compared With Healthy Volunteers"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["EARLY_PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.